Changes in Human Amniotic Fluid Fibrinolytic Inhibitor Levels during Pregnancy

Summary

The amniotic fluid (AF) when incubated with the patient’s own plasma diminishes the lytic activity of the plasma. It is suggested that this inhibition is due to the presence of fibrinolytic inhibitors in the AF. The inhibitors rate increases as pregnancy advances. Evaluating these inhibitors in a group of 65 women before and after the 38th week of pregnancy, a higher rate of fibrinolytic inhibitors is found after the 38th week. The said differences are statistically significant. For the moment it does not seem that the increasing of the inhibitors in the last part of pregnancy might be used as a fetal maturity test.

• References

• 1 Albrechtsen O. D, Trolle D. 1955; A fibrinolitic system in human amniotic fluid. Acta Haemotologica 14: 376.
• 2 Astrup T, Mullerzt S. 1952; The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics 40: 346.
• 3 Aznar J. 1972. Sindrome de Coagulación Intravascular Diseminada. In Ciscar F, Farreras P. (eds.) Diagnostico Hematologico . Jims.; Barcelona: p. 1867.
• 4 Bonnar J. 1973; Blood Coagulation and Fibrinolysis in Obstetrics. Clinics in Haematology 2: 213.
• 5 Courtney L. D, Allington M. 1972; Procoagulant properties of amniotic fluid. American Journal of Obstetrics and Gynecology 113: 911.
• 6 Hawkey C. M, Stafford J. L. 1964; A standard clot method for assay of plasminogen activators anti-activators and plasmin. Journal of Clinical Pathology 17: 175.
• 7 Hernandez A, Parrilla J. J, Aznar J, Gilabert J, Estelles A. 1975. Valoración de la actividad fibrinolítica del líquido amniótico. Sangre; (in press).
• 8 Peterson E. P, Taylor H. B. 1970; Amniotic fluid embolism: an analysis of 40 cases. Obstetrics and Gynecology 35: 787.
• 9 Phillips L. L, Davidson E. C. 1972; Procoagulant properties of amniotic fluid. American Journal of Obstetrics and Gynecology 113: 911.
• 10 Pritchard J. A. 1973; Haematological Problems Associated with Delivery, Placental Abruption, Retained Dead Fetus and Amniotic Fluid Embolism. Clinics in Haematology 2: 563.
• 11 Uszynski M, Uzynski-Folejewska R. 1969; Plasminogen activator and urokinasa inhibitor in myometrium placenta and amniotic fluid. American Journal of Obstetrics and Gynecology 105: 1041.
• 12 Weiner A. E, Reíd D. E, Roby C. C. 1949; Hemostatic activity of amniotic fluid. Science 110: 190.